Article
Molecular classification of endometrial carcinoma: clinical utility of an NGS panel with targeted detection of 116 cancer-related genes.
Pathology oncology research : POR - 1 Jan 2026
Chen Lingfeng, You Zhijie, Yu Xunbin, Wu Yijuan, Chen Xin, Lin Jie
Abstract excerpt
Background: This study aimed to evaluate the efficacy of a single-test, targeted DNA next-generation sequencing (NGS) panel in classifying endometrial carcinoma (EC) into molecular subtypes and to compare its performance with that of the established Sanger sequencing + immunohistochemistry (Sanger + IHC) molecular classification. Methods: Targeted DNA NGS was performed on 131 samples using the clinically...
Topics
- Humans
- Female
- Endometrial Neoplasms
- High-Throughput Nucleotide Sequencing
- Biomarkers, Tumor
- Mutation
- Middle Aged
- Microsatellite Instability
- Aged
- Immunohistochemistry
- Tumor Suppressor Protein p53
